Published in Leuk Lymphoma on November 08, 2017
Clinical impact of clonal and subclonal TP53, SF3B1, BIRC3, NOTCH1, and ATM mutations in chronic lymphocytic leukemia. Blood (2016) 0.98
Genomic and immunohistochemical profiles of enteropathy-associated T-cell lymphoma in Japan. Mod Pathol (2015) 0.86
MYC in DLBCL: partners matter. Blood (2015) 0.80
Clinical impact of MYD88 mutations in chronic lymphocytic leukemia. Blood (2016) 0.75
Genome-wide association analysis implicates dysregulation of immunity genes in chronic lymphocytic leukaemia. Nat Commun (2017) 0.75
Definition of MYC genetic heteroclonality in diffuse large B-cell lymphoma with 8q24 rearrangement and its impact on protein expression. Mod Pathol (2016) 0.75
Combined copy number and mutation analysis identifies oncogenic pathways associated with transformation of follicular lymphoma. Leukemia (2016) 0.75
HHV8-related lymphoid proliferations: a broad spectrum of lesions from reactive lymphoid hyperplasia to overt lymphoma. Mod Pathol (2017) 0.75
Mutations of MAP2K1 are frequent in pediatric-type follicular lymphoma and result in ERK pathway activation. Blood (2017) 0.75
Expression of a truncated B lymphocyte-induced maturation protein-1 isoform is associated with an incomplete plasmacytic differentiation program in chronic lymphocytic leukemia. Leuk Lymphoma (2017) 0.75
SOX11 promotes tumor protective microenvironment interactions through CXCR4 and FAK regulation in mantle cell lymphoma. Blood (2017) 0.75
Signatures of TOP1 transcription-associated mutagenesis in cancer and germline. Nature (2022) 0.75
Clinical impact of the subclonal architecture and mutational complexity in chronic lymphocytic leukemia. Leukemia (2017) 0.75